Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Background: Continuous glucose monitoring (CGM), which studies have shown is beneficial for adults with type 1 diabetes, has not been well-evaluated in those with type 2 diabetes receiving insulin. Objective: To determine the effectiveness of CGM in adults with type 2 diabetes receiving multiple daily injections of insulin. Design: Randomized clinical trial. (The protocol also included a type 1 diabetes cohort in a parallel trial and subsequent second trial.) (ClinicalTrials.gov: NCT02282397). Setting: 25 endocrinology practices in North America. Patients: 158 adults who had had type 2 diabetes for a median of 17 years (interquartile range, 11 to 23 years). Participants were aged 35 to 79 years (mean, 60 years [SD, 10]), were receiving multiple daily injections of insulin, and had hemoglobin A1c (HbA1c) levels of 7.5% to 9.9% (mean, 8.5%). Intervention: Random assignment to CGM (n = 79) or usual care (control group, n = 79). Measurements: The primary outcome was HbA1c reduction at 24 weeks. Results: Mean HbA1c levels decreased to 7.7% in the CGM group and 8.0% in the control group at 24 weeks (adjusted difference in mean change, -0.3% [95% CI, -0.5% to 0.0%]; P = 0.022). The groups did not differ meaningfully in CGM-measured hypoglycemia or quality-of-life outcomes. The CGM group averaged 6.7 days (SD, 0.9) of CGM use per week. Limitation: 6-month follow-up. Conclusion: A high percentage of adults who received multiple daily insulin injections for type 2 diabetes used CGM on a daily or near-daily basis for 24 weeks and had improved glycemic control. Because few insulin-treated patients with type 2 diabetes currently use CGM, these results support an additional management method that may benefit these patients. Primary Funding Source: Dexcom.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Benefits of CGM in this population include reductions in A1C, fewer severe hypoglycemia events in children and adults, increased TIR, as well as significant reductions in hospitalizations for severe hypoglycemia and DKA.156,162–168”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [156]
In the citing paper
“The clinical efficacy of CGM has been demonstrated in numerous retrospective studies and RCTs of individuals with T1D regardless of insulin delivery method.156–161”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [156]
In the citing paper
“In addition, CGM use has been reported to reduce fear of hypoglycemia and increase confidence in avoiding/treating hypoglycemia.156,174,175”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [156]
In the citing paper
“A1C is currently recognized as the key surrogate marker for the development of longterm diabetes complications in people with type 1 and type 2 diabetes and has been used the primary endpoint for many CGM studies (1; 3; 4; 6; 32; 33).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [4]
In the citing paper
“Numerous studies have demonstrated significant clinical benefits of CGM use in people with diabetes regardless of insulin delivery method (1-15).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [4]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Assessing Psychosocial Distress in Diabetes
Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mullan, J., & Jackson, R. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.626 · Cited by 1,575
Self-citationContinuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185 · cited 3×
“org), was identical to that of a parallel trial in patients with type 1 diabetes (12), which also had a second phase assessing insulin pump initiation.”
BackgroundResultSelf-citationEffect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Self-citationClarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.517 · Cited by 651
Self-citationHaak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-016-0223-6 · Cited by 623
Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541
Yeh, H.-C., Brown, T. T., Maruthur, N., Ranasinghe, P., Berger, Z., Suh, Y. D., Wilson, L. M., Haberl, E. B., Brick, J., Bass, E. B., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00508 · Cited by 493
Cited by
Items 101–200 of 636
Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 Disease
Klupa, T., Czupryniak, L., Dzida, G. J., Fichna, P., Jarosz-Chobot, P. A., Gumprecht, J., Myśliwiec, M., Szadkowska, A., Bomba-Opon, D. A., Czajkowski, K., et al. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01431-3 · Cited by 94
Grace, T., & Salyer, J. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0212 · Cited by 64
Aleppo, G., & Webb, K. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818813581 · Cited by 69
Freckmann, G., Link, M., Pleus, S., Westhoff, A., Kamecke, U., & Haug, C. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0105 · Cited by 64
Selecting the Appropriate Continuous Glucose Monitoring System – a Practical Approach
Adolfsson, P., Parkin, C. G., Thomas, A., & Krinelke, L. G. (2018) · European Endocrinology · doi:10.17925/ee.2018.14.1.24 · Cited by 63
Ndumele, C. E., Rodríguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M. S., Bangalore, S., Bozkurt, B., Breathett, K. K., Clarke, S. L., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001453 · Cited by 151
Associations between HbA1c and continuous glucose monitoring‐derived glycaemic variables
Hirsch, I. B., Welsh, J. B., Calhoun, P., Puhr, S., Walker, T. C., & Price, D. A. (2019) · Diabetic Medicine · doi:10.1111/dme.14065 · Cited by 62
Self-citationDehghani Zahedani, A., Shariat Torbaghan, S., Rahili, S., Karlin, K., Scilley, D., Thakkar, R., Saberi, M., Hashemi, N., Perelman, D., Aghaeepour, N., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01081-3 · Cited by 62
Riveline, J.-P., Roussel, R., Vicaut, E., de Pouvourville, G., Detournay, B., Emery, C., Levrat-Guillen, F., & Guerci, B. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0085 · Cited by 64
Christiansen, M. P., Klaff, L. J., Bailey, T. S., Brazg, R., Carlson, G., & Tweden, K. S. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0020 · Cited by 62
Health Care Disparities in Use of Continuous Glucose Monitoring
Isaacs, D., Bellini, N. J., Biba, U., Cai, A., & Close, K. L. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0268 · Cited by 61
The Glucose Management Indicator: Time to Change Course?
Selvin, E. (2024) · Diabetes Care · doi:10.2337/dci23-0086 · Cited by 69
Choe, H. J., Rhee, E.-J., Won, J. C., Park, K. S., Lee, W.-Y., & Cho, Y. M. (2022) · Diabetes Care · doi:10.2337/dc22-0764 · Cited by 59
“In the DIAMOND study on patients with T2D where hypoglycemic events were infrequent at baseline in spite of multiple daily injections (the time <70 mg/dL only 11 min per day), use of rtCGM reduced HbA1c levels as well (9).”
BackgroundMethodDigital Technology for Diabetes
Hughes, M. S., Addala, A., & Buckingham, B. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2215899 · Cited by 59
Majithia, A. R., Kusiak, C. M., Armento Lee, A., Colangelo, F. R., Romanelli, R. J., Robertson, S., Miller, D. P., Erani, D. M., Layne, J. E., Dixon, R. F., et al. (2020) · Journal of Medical Internet Research · doi:10.2196/21778 · Cited by 58
Landscape of Continuous Glucose Monitoring (CGM) and Integrated CGM: Accuracy Considerations
Bailey, T. S., & Alva, S. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0236 · Cited by 63
Ndumele, C. E., Rodriguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M., Bangalore, S., Bozkurt, B., Breathett, K., Clarke, S. L., et al. (2026) · JACC · doi:10.1016/j.jacc.2026.03.056 · Cited by 90
Reference Guide for Integrating Continuous Glucose Monitoring Into Clinical Practice
Kruger, D. F., Edelman, S. V., Hinnen, D. A., & Parkin, C. G. (2019) · The Diabetes Educator · doi:10.1177/0145721718818066 · Cited by 55
Self-citationChamberlain, J. J., Doyle-Delgado, K., Peterson, L., & SKOLNIK, N. (2019) · Annals of Internal Medicine · doi:10.7326/m19-1638 · Cited by 60
Diabetes mellitus type 2 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Sukhareva, O. Y., Galstyan, G. R., Tokmakova, A. Y., Nikonova, T. V., Surkova, E. V., Кононенко, И. В., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12507 · Cited by 69
Wilmot, E. G., Lumb, A. N., Hammond, P. J., Murphy, H. R., SCOTT, E. M., Gibb, F. W., Platts, J. K., & Choudhary, P. (2020) · Diabetic Medicine · doi:10.1111/dme.14433 · Cited by 57
Galindo, R. J., Ali, M. K., Funni, S. A., Dodge, A. B., Kurani, S. S., Shah, N. D., Umpierrez, G. E., & McCoy, R. G. (2022) · Diabetes Care · doi:10.2337/dc21-1579 · Cited by 53
Continuous Glucose Monitoring Use in Older Adults for Optimal Diabetes Management
Munshi, M. N. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0111 · Cited by 63
Technology Integration: The Role of the Diabetes Care and Education Specialist in Practice
Isaacs, D., Cox, C., Schwab, K., Oser, T. K., Rinker, J., Mason, M. J., Greenwood, D. A., & Albanese-O’Neill, A. (2020) · The Diabetes Educator · doi:10.1177/0145721720935123 · Cited by 53
Elliott, T., Beca, S., Beharry, R., Tsoukas, M. A., Zarruk, A., & Abitbol, A. (2021) · Diabetes and Vascular Disease Research · doi:10.1177/14791641211021374 · Cited by 49
de Kreutzenberg, S. V. (2022) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-022-00524-7 · Cited by 53
Continuous glucose monitoring in cystic fibrosis – A practical guide
Chan, C. L., Ode, K. L., Granados, A., Moheet, A. A., Moran, A., & Hameed, S. A. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.08.025 · Cited by 51
Munshi, M. N., Slyne, C., DAVIS, D. J., Michals, A. L., Sifre, K., Dewar, R., Atakov-Castillo, A., & Toschi, E. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0246 · Cited by 55
Self-citationHow Continuous Glucose Monitoring Can Motivate Self-management: Can Motivation Follow Behaviour?
Vallis, M., Ryan, H., Berard, L., Cosson, E., Kristensen, F. B., Levrat-Guillen, F., Naiditch, N., Rabasa-Lhoret, R., & Polonsky, W. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.04.001 · Cited by 48
Self-citationCeriello, A., de Valk, H. W., Guerci, B., Haak, T., Owens, D. R., Canobbio, M., Fritzen, K., Stautner, C., & Schnell, O. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108053 · Cited by 52
Effect of CGM Access Expansion on Uptake Among Patients on Medicaid With Diabetes
Ni, K., Tampe, C. A., Sol, K., Richardson, D. B., & Pereira, R. I. (2023) · Diabetes Care · doi:10.2337/dc22-1287 · Cited by 47
Roldan, V. D. T., Urtecho, M., Nayfeh, T., Firwana, M., Muthusamy, K., Hasan, B., Abd‐Rabu, R., Maraboto, A., Qoubaitary, A., Prokop, L. J., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac601 · Cited by 47
Dicembrini, I., Mannucci, E., Monami, M., & Pala, L. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13845 · Cited by 49
Polonsky, W. H., Layne, J. E., Parkin, C. G., Kusiak, C. M., Barleen, N. A., Miller, D. P., Zisser, H., & Dixon, R. F. (2020) · Clinical Diabetes · doi:10.2337/cd19-0105 · Cited by 46
Self-citationContinuous Glucose Monitoring and Physical Activity
Schubert-Olesen, O., Kröger, J., Siegmund, T., Thurm, U., & Halle, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912296 · Cited by 72
Crawford, A. L., & Laiteerapong, N. (2024) · Annals of Internal Medicine · doi:10.7326/aitc202406180 · Cited by 54
Deiss, D., Irace, C., Carlson, G., Tweden, K. S., & Kaufman, F. R. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0159 · Cited by 44
Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes
Kravarusic, J., & Aleppo, G. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.006 · Cited by 42
Oser, T. K., Litchman, M. L., Allen, N. A., Kwan, B. M., Fisher, L., Jortberg, B. T., Polonsky, W. H., & Oser, S. M. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01408-1 · Cited by 43
Self-citationContinuous Glucose Monitoring for Prediabetes: What Are the Best Metrics?
Zahalka, S. J., Galindo, R. J., Shah, V. N., & Wang, C. C. L. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241242487 · Cited by 231
Comprehensive Telehealth Model to Support Diabetes Self-Management
Aleppo, G., Gal, R. L., Raghinaru, D., Kruger, D., Beck, R. W., Bergenstal, R. M., Cushman, T., Hood, K. K., Johnson, M. L., McArthur, T., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.36876 · Cited by 42
Self-citationComparisons of Fifth-, Sixth-, and Seventh-Generation Continuous Glucose Monitoring Systems
Welsh, J. B., Psavko, S., Zhang, X., Gao, P., & Balo, A. K. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221099879 · Cited by 46
Forlenza, G. P., Messer, L. H., Berget, C., Wadwa, R. P., & Driscoll, K. A. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1078-1 · Cited by 47
Montaser, E., Fabris, C., & Kovatchev, B. P. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0104 · Cited by 46
Li, X., Geng-Ji, J.-J., Quan, Y.-Y., Qi, L., Sun, Q., Huang, Q., Jiang, H., Sun, Z., Liu, H., & Xie, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1023713 · Cited by 50
Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases
ALMURASHI, A. M., Rodriguez, E., & Garg, S. K. (2023) · Journal of the Indian Institute of Science · doi:10.1007/s41745-022-00348-3 · Cited by 66
Chesser, H., Srinivasan, S., Puckett, C., Gitelman, S. E., & Wong, J. C. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221139873 · Cited by 40
Chow, K. W., Kelly, D. J., Rieff, M. C., Skala, P. A., Kravets, I., Charitou, M. M., Morley, E. J., Gupta, R., & Miller, J. D. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820985263 · Cited by 40
Choudhary, P., Bellido, V., Graner, M., Altpeter, B., Cicchetti, A., Durand‐Zaleski, I., & Kristensen, F. B. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01132-9 · Cited by 47
Glycemic control in the critically ill: Less is more
Alhatemi, G., Aldiwani, H., Alhatemi, R., Hussein, M., Mahdai, S., & Seyoum, B. (2022) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.89a.20171 · Cited by 53
Lu, J., Ying, Z., Wang, P., Fu, M., Han, C., & Zhang, M. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15328 · Cited by 39
Billings, L. K., Parkin, C. G., & Price, D. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0163 · Cited by 39
Self-citationMontaser, E., Farhy, L. S., & Kovatchev, B. P. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae379 · Cited by 50
Lucidi, P., Porcellati, F., Bolli, G. B., & Fanelli, C. G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1065-6 · Cited by 38
Bellido, V., Aguilera, E., Cardona‐Hernandez, R., Díaz-Soto, G., de Villar, N. G. P., César, M. J. P., & Ampudia‐Blasco, F. J. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221088601 · Cited by 46
Layne, J. E., Jepson, L. H., Carite, A. M., Parkin, C. G., & Bergenstal, R. M. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0197 · Cited by 37
Self-citationGuerci, B., Levrat‐Guillen, F., Vicaut, É., de Pouvourville, G., Detournay, B., Emery, C., & Riveline, J. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0034 · Cited by 41
Reddy, M., & Oliver, N. S. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15504 · Cited by 47
Time-in-range as a target in type 2 diabetes: An urgent need
Saboo, B., Kesavadev, J., Shankar, A., Krishna, M. B., Sheth, S., Patel, V., & Krishnan, G. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e05967 · Cited by 44
Isitt, J. J., Roze, S., Sharland, H., Cogswell, G., Alshannaq, H. A., Norman, G. J., & Lynch, P. M. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01324-x · Cited by 43
Kim, J. Y., Jin, S.-M., Sim, K. H., Kim, B.-Y., Cho, J. H., Moon, J. S., Lim, S., Kang, E. S., Park, C.-Y., Kim, S. G., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06152-1 · Cited by 36
Kong, S.-Y., & Cho, M.-K. (2024) · Healthcare · doi:10.3390/healthcare12050571 · Cited by 36
“Studies have demonstrated that CGM use leads to improved self-management behaviors, enhanced blood glycemic control, effective reductions in HbA1c levels, and hypoglycemic improvements in diabetic patients [11–14].”
BackgroundGarg, S. K., Hirsch, I. B., Repetto, E., Snell‐Bergeon, J. K., Ulmer, B. J., Perkins, C., & Bergenstal, R. M. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15866 · Cited by 42
Self-citationLeahy, J. (. L., Aleppo, G., Fonseca, V. A., Garg, S. K., Hirsch, I. B., McCall, A. L., McGill, J. B., & Polonsky, W. H. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00222 · Cited by 34
Self-citationGalindo, R. J., Parkin, C. G., Aleppo, G., Carlson, A. L., Kruger, D. F., Levy, C. J., Umpierrez, G. E., & McGill, J. B. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0107 · Cited by 38
Self-citationA Data-Driven Approach to Classifying Daily Continuous Glucose Monitoring (CGM) Time Series
Lobo, B. J., Farhy, L. S., Shafiei, M., & Kovatchev, B. P. (2021) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2021.3103127 · Cited by 40
Aleppo, G., Hirsch, I. B., Parkin, C. G., McGill, J., Galindo, R., Kruger, D. F., Levy, C. J., Forlenza, G. P., Umpierrez, G. E., Grunberger, G., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0268 · Cited by 34
Self-citationNathanson, D., Eeg‐Olofsson, K., Spelman, T. D., Bülow, E., Kyhlstedt, M., Levrat‐Guillen, F., & Bolinder, J. (2024) · Diabetologia · doi:10.1007/s00125-024-06289-z · Cited by 40
Longitudinal Changes in Depression Symptoms and Glycemia in Adults With Type 1 Diabetes
Trief, P. M., Foster, N. C., Chaytor, N. S., Hilliard, M. E., Kittelsrud, J. M., Jaser, S. S., Majidi, S., Corathers, S. D., Bzdick, S., Adkins, D. W., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2441 · Cited by 34
Barua, S., Sabharwal, A., GLANTZ, N. M., Conneely, C., LAREZ, A. J., Bevier, W. C., & Kerr, D. E. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100853 · Cited by 36
Johnston, A. R., Poll, J. B., Hays, E., & Jones, C. W. (2022) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2022.100068 · Cited by 40
Continuous Glucose Monitoring to Optimize Management of Diabetes in Patients with Advanced CKD
Galindo, R. J., de Boer, I. H., Neumiller, J. J., & Tuttle, K. R. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04510422 · Cited by 36
Prasad‐Reddy, L., Godina, A., Chetty, A. K., Close Concerns, S. F., & Isaacs, D. (2022) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2022.18.2.116 · Cited by 43
Comparison of Glycemia Risk Index with Time in Range for Assessing Glycemic Quality
Kim, J. Y., Yoo, J. H., & Kim, J. H. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0264 · Cited by 36
Accuracy of continuous glucose monitoring in the hospital setting: an observational study
O’Connor, M. Y., Flint, K. L., Sabean, A., Ashley, A. L., Zheng, H., Yan, J., Steiner, B. A., Anandakugan, N., CALVERLEY, M. M., Bartholomew, R. A., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06250-0 · Cited by 38
Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes
Sato, T., Oshima, H., Nakata, K., Kimura, Y., Yano, T., Furuhashi, M., Tanno, M., Miki, T., & Miura, T. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12954 · Cited by 35
Advancing the Use of CGM Devices in a Non-ICU Setting
Wang, M., Singh, L. G., & Spanakis, E. K. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818821094 · Cited by 36
Satou, R., Cypress, M. W., Woods, T. C., Katsurada, A., Dugas, C. M., Fonseca, V. A., & Navar, L. G. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00402.2019 · Cited by 34
Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without Diabetes
Shah, V. N., Vigers, T., Pyle, L. L., Calhoun, P. M., & Bergenstal, R. M. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0544 · Cited by 41
Self-citationZhang, W., Liu, Y., Sun, B., Shen, Y., Li, M., Peng, L., Duan, H., Su, X., Lu, S., Tian, X., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-03480-9 · Cited by 32
Chagas, G. C. L., Teixeira, L., Clemente, M. R. C., Chagas, R. C. L., Pestana, D. V. S., Sombra, L. R. S., Lima, B. B., Galindo, R. J., & Abreu, M. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111986 · Cited by 39
Battelino, T., Lalic, N. M., Hussain, S., Ceriello, A., Majanović, S. K., Davies, S., Topsever, P., Heverly, J., Ulivi, F., Brady, K., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112111 · Cited by 36
Volčanšek, Š., Lunder, M., & Janež, A. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0131 · Cited by 33
Gal, R. L., Cohen, N. J., Kruger, D., Beck, R. W., Bergenstal, R. M., Calhoun, P., Cushman, T., Haban, A., Hood, K., Johnson, M. L., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa076 · Cited by 32
Self-citationBlood Glucose Monitoring in Adults and Children with Diabetes: Update 2021
CHENG, A. Y. Y., Feig, D. S., Ho, J., Siemens, R. L., BAJAJ, H. S., Gilbert, J. D., Houlden, R. L., Kim, J., MacKay, D., Rabi, D. M., et al. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.07.003 · Cited by 38
Davis, G. M., Bailey, R. J., Calhoun, P. M., Price, D. A., & Beck, R. W. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0489 · Cited by 37
Self-citationNorman, G. J., Paudel, M. L., Parkin, C. G., Bancroft, T., & Lynch, P. M. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0525 · Cited by 36
Current Perspectives on Management of Type 2 Diabetes in Youth
Singhal, S., & Kumar, S. (2021) · Children · doi:10.3390/children8010037 · Cited by 36
Tan, Y. Y., Suan, E., Koh, G. C., Suhairi, S. B., & Tyagi, S. (2024) · Archives of Public Health · doi:10.1186/s13690-024-01459-2 · Cited by 44
Singh, L. G., Levitt, D. L., Satyarengga, M., Pinault, L. F., Zhan, M., Sorkin, J. D., Fink, J. C., Umpierrez, G. E., & Spanakis, E. K. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819889640 · Cited by 36
LACY, M. E., Lee, K. E., Ataç, Ö., Heier, K., Fowlkes, J. L., Kucharska‐Newton, A., & Moga, D. C. (2024) · Clinical Diabetes · doi:10.2337/cd23-0051 · Cited by 35
Elian, V., Popovici, V., Ozon, E.-A., Musuc, A. M., Fița, A. C., Rusu, E., Radulian, G., & Lupuliasa, D. (2023) · Life · doi:10.3390/life13081663 · Cited by 41
Jangam, S. R., Dunn, T. C., Xu, Y., Hayter, G., & Ajjan, R. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000611 · Cited by 30
Psychosocial Aspects of Diabetes Technology
Polonsky, W. H. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.003 · Cited by 29
Self-citationOgawa, W., Hirota, Y., Osonoi, T., Tosaki, T., Kato, Y., Utsunomiya, K., Nishimura, R., & Nakamura, J. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13327 · Cited by 30
Goldenberg, R., Aroda, V. R., Billings, L. K., Christiansen, A. S. L., Donatsky, A. M., Rizi, E. P., Podgorski, G., Rašlová, K., Klonoff, D. C., & Bergenstal, R. M. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14504 · Cited by 34
Self-citationWilkie, G., Melnik, V. Y., Brainard, L., Antonioli, S. S., Nelson, B. B., Leung, K., & Leftwich, H. K. (2023) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2023.100969 · Cited by 34
Diabetic Kidney Disease: Is There a Role for Glycemic Variability?
Subramanian, S., & Hirsch, I. B. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0979-3 · Cited by 35
Adolfsson, P., Rentoul, D., Klinkenbijl, B., & Parkin, C. G. (2018) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2018.14.2.50 · Cited by 38
Shields, S., Thomas, R., Durham, J., Moran, J., Clary, J., & Ciemins, E. L. (2024) · Scientific Reports · doi:10.1038/s41598-024-83548-4 · Cited by 28
Metadata
- Authors
- Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., Aronson, R., Toschi, E., Kollman, C., Bergenstal, R., & for the DIAMOND Study Group*
- Affiliations
- Joslin Diabetes Center (US)
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2017-09-19
- Volume
- 167
- Issue
- 6
- Pages
- 365-374
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2753830550
- Semantic Scholar
- 4f35ac21c54271e1101cc587d928e543765ee06a
- Cited by
- 635
- References
- 31
- Citations by year
- 2026: 58 · 2025: 91 · 2024: 95 · 2023: 77 · 2022: 77 · 2021: 85 · 2020: 43 · 2019: 56 · 2018: 46 · 2017: 6
- FWCI
- 32.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- continuous glucose monitoring, type 2 diabetes, multiple daily insulin injections, glycemic control, HbA1c reduction, hypoglycemia, quality of life, usual care, type 1 diabetes
- MeSH terms
- Adult, Aged, Bacterial Proteins, Diabetes Mellitus, Type 2, Drug Administration Schedule, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Membrane Proteins, Middle Aged, Quality of Life, Blood Glucose Self-Monitoring, Patient Satisfaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.